| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/08/2010 | WO2010075973A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators |
| 07/08/2010 | WO2010075863A1 Arginase inhibitors for the treatment of depression |
| 07/08/2010 | WO2010075635A1 Combination therapies using nap |
| 07/08/2010 | WO2010075611A1 Composition comprising proanthocyanidin, proteolytic enzyme and aloe vera/agave species substance |
| 07/08/2010 | WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators |
| 07/08/2010 | WO2010053435A3 Compounds and methods for the treatment of inflammatory diseases of the cns |
| 07/08/2010 | WO2010045575A3 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders |
| 07/08/2010 | WO2010043561A3 Regenerative therapy |
| 07/08/2010 | WO2010012806A3 Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| 07/08/2010 | WO2010009139A3 Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors |
| 07/08/2010 | WO2009129361A3 Bryostatin analogues and methods of making and using thereof |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100173997 2,4,6-trisubstituted phenols having anesthetic properties |
| 07/08/2010 | US20100173992 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 07/08/2010 | US20100173990 Transglutaminase Inhibitor Comprising Chlorogenic Acid And A Method For Producing Thereof |
| 07/08/2010 | US20100173983 Method for inducing autophagy |
| 07/08/2010 | US20100173980 Antiviral oligonucleotides targeting rsv |
| 07/08/2010 | US20100173969 Therapeutic agent |
| 07/08/2010 | US20100173968 Sub-type selective azabicycloalkane derivatives |
| 07/08/2010 | US20100173960 The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases |
| 07/08/2010 | US20100173951 Novel methods |
| 07/08/2010 | US20100173949 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 07/08/2010 | US20100173947 New Indications for Direct Thrombin Inhibitors |
| 07/08/2010 | US20100173942 Phosphodiesterase 4 inhibitors |
| 07/08/2010 | US20100173941 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia |
| 07/08/2010 | US20100173940 Non-mucoadhesive film dosage forms |
| 07/08/2010 | US20100173938 Nerve cell death inhibitor |
| 07/08/2010 | US20100173935 Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia |
| 07/08/2010 | US20100173932 Sub-type selective amides of diazabicycloalkanes |
| 07/08/2010 | US20100173929 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/08/2010 | US20100173927 administering 2,3,4,4a,13b-hexahydro-2,10-dimethyldiben-[2,3:6,7]oxepino[4,5c]pyridine-4a-ol] for treating pain associated with surgery, inflammation, cancer and neuropathic pain; pain management |
| 07/08/2010 | US20100173926 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations |
| 07/08/2010 | US20100173925 Oxyindole derivatives |
| 07/08/2010 | US20100173924 Novel heterocycle compounds and uses thereof |
| 07/08/2010 | US20100173914 Pharmaceuticals, compositions and methods of making and using the same |
| 07/08/2010 | US20100173912 Novel Compound |
| 07/08/2010 | US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 07/08/2010 | US20100173907 Method of treatment of aggression |
| 07/08/2010 | US20100173902 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
| 07/08/2010 | US20100173901 Substituted Heterocyclic Compounds |
| 07/08/2010 | US20100173898 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 07/08/2010 | US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 07/08/2010 | US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 07/08/2010 | US20100173894 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 07/08/2010 | US20100173893 Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation |
| 07/08/2010 | US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/08/2010 | US20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease |
| 07/08/2010 | US20100173889 Substituted Pyrimidine and Triazine Compounds |
| 07/08/2010 | US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| 07/08/2010 | US20100173883 7-hydroxyepiandrosterone having neuroprotective activity |
| 07/08/2010 | US20100173881 Compositions for the treatment of inflammatory disorders |
| 07/08/2010 | US20100173878 Organic compounds |
| 07/08/2010 | US20100173876 Oil-based nsaid compositions and methods for making and using same |
| 07/08/2010 | US20100173872 Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin |
| 07/08/2010 | US20100173850 Improved Peptide Composition |
| 07/08/2010 | US20100173849 Neo-tryptophan |
| 07/08/2010 | US20100173841 Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen |
| 07/08/2010 | US20100173828 Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof |
| 07/08/2010 | US20100173827 Role of proline rich peptides in cellular communication mechanisms and treatment of diseases |
| 07/08/2010 | US20100173823 Alpha2c adrenoreceptor agonists |
| 07/08/2010 | US20100173008 Method of treating or alleviating the symptoms of alesion in mammal |
| 07/08/2010 | US20100173004 Preventive and therapeutic vaccine for alzheimer's disease |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172991 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
| 07/08/2010 | US20100172989 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 07/08/2010 | US20100172982 Sustained release formulations of divalproex sodium |
| 07/08/2010 | US20100172971 Compositions for Inhibiting NADPH Oxidase Activity |
| 07/08/2010 | US20100172966 Methods and compositions for cellular reprogramming |
| 07/08/2010 | US20100172963 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering |
| 07/08/2010 | US20100172919 Noveltreatment for neurological disorders |
| 07/08/2010 | US20100172916 Substituted hydroxyphenylamine compounds |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172907 Anti-Abeta antibodies and their use |
| 07/08/2010 | US20100172904 Mcp1 fusions |
| 07/08/2010 | US20100172879 Amyloid beta peptides and methods of use |
| 07/08/2010 | US20100172869 Method for treating multiple sclerosis |
| 07/08/2010 | DE202010004094U1 Orale Zusammensetzung eines Antipsychotikums mit verzögerter Freisetzung The oral composition of antipsychotic sustained release |
| 07/08/2010 | DE102009003980A1 Propofol in triheptanoinhaltiger Trägeremulsion Propofol emulsion carrier in triheptanoinhaltiger |
| 07/08/2010 | CA2783331A1 Pregnenolone sulfate for the treatment of neurologic disorders |
| 07/08/2010 | CA2748811A1 Stroke-generated angiogenesis enhancers and uses thereof |
| 07/08/2010 | CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 07/08/2010 | CA2747602A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same |
| 07/08/2010 | CA2747094A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators |
| 07/08/2010 | CA2746307A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | CA2745503A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same |
| 07/07/2010 | EP2204365A1 Alkylsulfone derivative |
| 07/07/2010 | EP2204364A1 Polymorphs of donepezil salts, preparation methods and uses thereof |
| 07/07/2010 | EP2204363A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission |
| 07/07/2010 | EP2204183A1 Treatment of neuroblastoma |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP2204172A1 Agent having neurotrophic factor-like activity |
| 07/07/2010 | EP2203459A1 Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 07/07/2010 | EP2203458A2 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 07/07/2010 | EP2203454A1 Tricyclic heterocyclic derivatives |
| 07/07/2010 | EP2203450A2 Chiral synthesis of diazepinoquinolines |
| 07/07/2010 | EP2203445A1 Azabicyclo ý3. 1. o¨hexyl derivatives as modulators of dopamine d3 receptors |
| 07/07/2010 | EP2203444A1 Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate |
| 07/07/2010 | EP2203439A1 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones |
| 07/07/2010 | EP2203438A1 Cyanoisoquinoline |